baber/WOPTO huggingface dataset:
Patent NZ-232223-A (NZ)
Title: Alternate burst communication for cordless phones re-established after channel failure
Inventor: BARNES NIGEL EVERARD
IPC: H04W72/08
Filed: 1990-01-24
Abstract: A communication procedure suitable for a cordless telephone system involves time division duplex radio communication between a handset 11 and a base station 3 using alternating bursts of transmission over a single radio channel. Once a radio link has been set up, initial transmissions carry a synchronisation logical channel S and a signalling logical channel D multiplexed together, but the link may switch to bursts carrying a communications logical channel B for the speech data and the signalling logical channel D. Burst synchronisation is achieved by the asynchronous detection of words in a synchronisation channel S. These words have bit patterns reducing the probability of incorrect asynchronous detection of them.   If one part ceases to receive handset signals from the other, it transmits a special signal, informing the other part. This enables both parts to detect the failure of a link at substantially the same time, so that their actions to re-establish the link are synchronised.
Patent NZ-233127-A (NZ)
Title: Imidazole derivatives and pharmaceutical compositions
Inventor: KARJALAINEN ARTO JOHANNES
IPC: C07D233/54
Filed: 1990-03-29
Abstract: Novel imidazole derivatives of the formula <CHEM> wherein R1, R2, R min 1 and R min 2, which can be the same or different, are H, CH3, C2H5, C3H7, OCH3, OH, CH2OH, NO2, NH2, CN, CF3, CHF2, CH2F or halogen; R min  is H or <CHEM> where R3 is H, CH3 or halogen; R4 is H, R5 is H or OH, R6 is H or OH and R7 is H or R4 and R6 together form a bond or R5 and R7 together form a bond; X and Y, which can be the same or different, are a bond, a straight C1-2-alkyl or the corresponding alkenyl and z is 0 to 2 and <CHEM> wherein R1, R2, R min 1, R min 2 and R min  are as defined before, R4 is H or OH and R5 is H or R4 and R5 together form a bond and y is 0 to 4, and their non-toxic salts exhibit aromatase and desmolase inhibiting properties. Very selective aromatase inhibiting compounds are valuable in the treatment of estrogen dependent diseases, e.g. breast cancer.
Patent NZ-238954-A (NZ)
Title: Wound debriding composition containing a neutral protease produced by bacteria of the vibrio genus
Inventor: FORTNEY DONALD ZANE
IPC: A61P17/02
Filed: 1991-07-12
Abstract: A composition for treating wounds comprising at least one pharmaceutically acceptable carrier admixed with an effective amount of a protease selected from the group consisting of:   (a) an extracellular neutral protease produced by cultivation of a microorganism belonging to the genus Vibrio, said protease characterized by the following properties:   i. hydrolyzes components of necrotic tissue including denatured collagen, elastin and fribrin;   ii. does not substantially hydrolyze native tissue in vivo; and iii. exhibits stable activity when stored at 25 DEG C in a topical formulation;   (b) a protease expressed by recombinant host cells which have been transformed or transfected with an expression vector for said protease (a); and (c) mutants and hybrids of proteases (a) and (b) which are characterized by the properties (i) to (iii).   <IMAGE>   <IMAGE> <IMAGE>
Patent NZ-250549-A (NZ)
Title: Preparation of anilide derivatives and corresponding chloracetanilides
Inventor: BADER ROLF
IPC: C07C211/46
Filed: 1993-12-22
Abstract: A process for the preparation of 2-alkyl-6-methyl-N-(1'methoxy-2'-propyl)-aniline by catalytic reductive alkylation wherein at least one mole equivalent of methoxyacetone is reacted with one mole equivalent of 2-alkyl-6-methyl-aniline in a liquid medium without an additional solvent, in the presence of a platinised carbon catalyst and hydrogen and in the presence of an acid cocatalyst under a hydrogen pressure of between 2 x 10<5> and 1 x 10<6> Pa at a temperature between 20 and 80  DEG C, characterised in that the reaction mixture contains water from the beginning of the reaction and after the hydrogenation, base is added, the reaction mixture is filtered to separate the catalyst and the title compound recovered from the filtrate. The process is particularly useful for the preparation of N-substituted chloracetanilide herbicides.
Patent NZ-257086-A (NZ)
Title: Continuous composter with conveyor consisting of trays moved step-by-step by a ram through enclosed tunnel
Inventor: WRIGHT JAMES
IPC: C05F9/02
Filed: 1993-10-19
Abstract: A continuous composter comprises a train of composting in an elongate enclosed tunnel. The trays run on tracks above the level of the base of the tunnel. Garbage enters at one end of the tunnel and compost is removed from the other end. A ram shunts the trays stepwise through the tunnel. The tracks may be U-channels the webs of which are connected to tunnel side walls. The trays rest on one of the U and the other leg of the U extends over the edge of the tray to protect it from being fouled by garbage. Computer control may adjust proportions of aerating gas with recycled gas.
Patent NZ-270181-A (NZ)
Title: Use of benzothiophene derivatives for inhibiting central nervous system problems in post-menopausal women
Inventor: BRYANT HENRY UHLMAN
IPC: A61K31/38
Filed: 1994-12-19
Abstract: A method of inhibiting one or more CNS disorders in a post-menopausal woman comprising administering to a female human in need of treatment an effective amount of a compound having the formula <CHEM>     wherein R<1> and R<3> are independently hydrogen, -CH3, <CHEM>  wherein Ar is optionally substituted phenyl; R<2> is selected from the group consisting of pyrrolidine, hexamethyleneamino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
Patent NZ-314699-A (NZ)
Title: Benzothiophene derivatives for use in pharmaceuticals to prevent bone loss
Inventor: DRAPER MICHAEL WILLIAM
IPC: A61P43/00
Filed: 1995-02-07
Abstract: Raloxifene of the formula 1 in a dosage form of 60mg per dosage unit for inhibiting bone loss and lowering serum cholesterol levels in oral, tablet, capsule, and suspension form.
Patent NZ-323485-A (NZ)
Title: Painting tool with different brush positions
Inventor: MARTINSSON KENNETH
IPC: A46B5/00
Filed: 1996-11-14
Abstract: The present invention is for a paint applicator, brush or similar painting tool, the handle (2) of which can easily be set between two different positions during ongoing work. Shaft and bristle parts of a paint-brush according to the invention have been divided along a plane which somewhat deviates from a plane which is parallel to an imaginary axis along the paint-brush parallel to the bristles. The two parts of the brush are joined by a shaft or the like which is at right angle to the dividing plane.
Patent NZ-331949-A (NZ)
Title: Circulator with overlying strips to contain ferrite blocks
Inventor: BUTLAND ROGER JOHN
IPC: H01P1/383
Filed: 1997-04-02
Abstract: Ferrite block(s) 40, 41 are contained within overlying crossing strips (not shown) with one face of the block(s) located adjacent to the strips and the other face exposed to allow direct contact with a circulator housing body (not shown).
Patent NZ-332135-A (NZ)
Title: Ligament fixing element comprising a hollow, cylindrical element
Inventor: LO KOKBING
IPC: A61F2/08
Filed: 1997-04-01
Abstract: Disclosed is a fixing element for connecting a ligament to a bone part of a human or animal. The fixing element includes a hollow, substantially cylindrical element fixable in a continuous opening in the bone part, and an engaging element for the ligament anchorable in the cylindrical element at least at two mutually differing axial positions.
Patent NZ-334635-A (NZ)
Title: Treatment of autoimmune diseases such as rheumatoid arthritis with a vaccine
Inventor: BOLTON ANTHONY E
IPC: A61K35/14
Filed: 1997-08-11
Abstract: An autoimmune vaccine is provided for administration to human patients to alleviate the symptoms of autoimmune diseases such as rheumatoid arthritis. The vaccine comprises an aliquot of the patient's blood, containing, inter alia , leukocytes having upregulated expression of various cell surface markers and lymphocytes containing decreased amounts of certain stress proteins. It is produced by subjecting the blood aliquot extracorporeally to certain stressors, namely oxidizing agents, UV radiation and elevated temperature.
Patent NZ-502460-A (NZ)
Title: Energy absorbing bearing comprising end plates connected to an integral laminate
Inventor: ROBINSON WILLIAM HENRY
IPC: E02D31/08
Filed: 1998-07-13
Abstract: The energy absorbing bearing has a primary application in the seismic isolation of structures from the ground or parts of other structures. It may also be used to dampen other forces on structures on which it is installed.  The bearing consists of a pair of end plates, separated by a laminate of resilient and stiffening layers.  The resilient material is preferably rubber, and the stiffening layers comprise rigid plates of plastically deformable material.   The laminate is connected to the end plates at or adjacent to a central axis running from one end plate through said laminate to the other end plate.  The unconnected adjacent surface portions of the laminate are capable of limited movement relative to each end plate when an external force acts on the bearing.  Figure 1 illustrates an exploded view of a first embodiment.  The bearing has a pair of end plates (12 and 14), of which end plate (14) would be fixed to a foundation portion of a structure being isolated.  Between the end plates is a laminate comprising a stack of steel plates (18, 19, and 20) embedded in an elastomer (16).  The insert (22) comprises a plastically deformable material, preferably lead.  Alternatively, the bearing may have an empty core surrounded by the laminate, or no insert or hollow core, just the laminate between the end plates.  In an alternative embodiment, the top end plate is not secured to the laminate, but constrained by guiding means from moving horizontally relative to the laminate, while being capable of reciprocal vertical movement relative to the laminate.
Patent NZ-504938-A (NZ)
Title: Tumor antigen peptide derivatives capable of binding to HLA-A24 antigen
Inventor: SHICHIJO SHIGEKI
IPC: C12N5/08
Filed: 1998-12-02
Abstract: Use of a tumor antigen peptide derivative capable of binding to HLA-A24 antigen and thus being recognized by cytotoxic T-cells, as a therapeutic treating agent for tumors.
Patent NZ-504985-A (NZ)
Title: Free radical initiated polymerisation method using an anionic surfactant as a stablizing agent
Inventor: BLEASE TREVOR GRAHAM
IPC: C08F2/26
Filed: 1998-12-18
Abstract: A method of free radical initiated addition polymerization of at least one ethylenically unsaturated monomer in which the dispersed phase is stabilized by a surfactant including at least one anionic surfactant of the formula (I) R1-(OA)n-X or a salt thereof wherein R1 is a C16-22 hydrocarbyl group including two ethylenic double bonds; OA is an oxyalkylene group; n is 2 to 60 and X is a group including at lest one acidic H atom. The polymer obtained is useful as a binder or film former in coatings, water borne adhesives or inks or as a binder for non woven fabrics, concrete and cement additives.
Patent NZ-505998-A (NZ)
Title: Gastroprotected omeprazole microgranules, method for obtaining same and pharmaceutical preparations
Inventor: PATRICE DEBREGEAS
IPC: A61K31/44
Filed: 1998-08-10
Abstract: Omeprazole granules comprising an active layer having omeprazole and a hydrophobic substance, and an external gastroprotective layer.
Patent NZ-510631-A (NZ)
Title: Esters of (+)-alpha-(2,3- dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol and their use as prodrugs of the 5HT2A receptor antagonist MDL 100,907
Inventor: CARR ALBERT A
IPC: A61P25/00
Filed: 1998-10-14
Abstract: Compounds of formula (I), wherein R is C4-20alkyl, or a stereoisomer or a pharmaceutically acceptable salt thereof. Also described is the use of the compounds of formula (I) for the manufacture of medicaments for antagonising the effects of serotonin at the 5HT2A receptor in a patient.
Patent NZ-511266-A (NZ)
Title: Method for increasing plant productivity using glutamic acid and glycolic acid
Inventor: KINNERSLEY ALAN M
IPC: A01G7/06
Filed: 1999-10-28
Abstract: Compositions including glutamic acid and either glycolic acid or polyglycolic acid are described as are such compositions that include a calcium salt, preferably calcium nitrate. Methods of treating a plant including treating the plant or seed with a composition including glutamic acid and either glycolic acid or polyglycolic acid are also described. Methods of treating a plant including treating the plant or seed with a composition that includes glutamic acid, a calcium salt and either glycolic acid or polyglycolic acid are also described. The methods and compositions of the present invention are advantageous in increasing plant productivity, including helping plants resist environmental stresses.
Patent NZ-512361-A (NZ)
Title: Methods and compositions for improving the developmental ability and quality of pre-implantation embryos
Inventor: THOMPSON JEREMY GILBERT ELLIOT
IPC: C12N5/06
Filed: 1999-12-22
Abstract: A method of improving the developmental ability and quality of in vitro cultured pre-implantation non-human mammalian embryos comprises the steps of: a) Culturing the pre-implantation embryos in vitro to the pre-compaction or pre-blastulation stage; b) Reducing the normal capacity of the embryos to generate ATP by oxidative phosphorylation either by partially reducing the oxygen content of the culture atmosphere or by use of one or more selective oxidative phosphorylation inhibitors and/or uncouplers; c) Culturing the embryos to the compaction or blastocyst stage; and d) Assessing the developmental ability and quality of the embryos for suitability for implantation. A method of improving the viability of an in vitro pure culture of non-human mammalian embryonic-derived cells comprises the steps of: a) Culturing the cells in vitro; b) Reducing the normal capacity of the cells to generate ATP by oxidative phosphorylation either by partially reducing the oxygen content of the culture atmosphere or by use of one or more selective oxidative phosphorylation inhibitors and/or uncouplers; c) Assessing the viability of the cells for use in nuclear transfer. Also described is a culture for improving the developmental and quality of pre-implantation mammalian embryos comprising at least one oxidative phosphorylation inhibitor and/or oxidative phosphorylation uncoupler, in combination with an animal mammalian embryo maintaining medium. The inhibitors is preferably selected from the group consisting of sodium azide, cyanide, rotenone and antimycin A, and any other group of compounds which act as inhibitors of oxidative phosphorylation, and the oxidative phosphorylation uncoupler is preferably selected from the group consisting of 2,4-dinitrophenol (DNP), carbonylcyanide p-trifluoro-methoxyphenylhydrazone (FCCP). The inhibitor and/or uncoupler are present in the culture medium at a concentration of from 0.001 to 1000mM.
Patent NZ-514164-A (NZ)
Title: Powdered human milk fortifier comprising 24%-55% protein, 1%-30% fat and 15%-75% carbohydrate plus an emulsifier
Inventor: BARRETT-REIS BRIDGET M
IPC: A23L33/15
Filed: 2000-04-07
Abstract: A   powdered  human  milk  fortifier  is   described, comprising  a  protein  component typically  present  in  an amount  of  from  24 wt/wt% to 55 wt/wt%  of  the  fortifier powder,  and a fat component typically present in an  amount of from 1 wt/wt% to 30 wt/wt% of the fortifier powder and  a carbohydrate  component present in a  quantity  of  from  15 wt/wt%  to  75 wt/wt% of the fortifier powder.   Preferably, the  powdered  human milk fortifier is provided  in  a  unit dose  container which holds from 0.5 gm to 10 gm of  powder. A  method of providing nutrition to preterm infants is  also described.   The  method involves adding a fortifier  powder to  human milk and administering the fortified human milk to a premature infant.
Patent NZ-516235-A (NZ)
Title: Method for purification of proteins
Inventor: WINGE STEFAN
IPC: A61K9/19
Filed: 2000-06-08
Abstract: A process for purifying antithrombin-III comprising: i) adding, to a solution comprising antithrombin-III, a saccharide and citrate in an amount sufficient for impurities to precipitate while antithrombin-III essentially remains in solution; ii) allowing impurities to precipitate; iii) removing the precipitated impurities, thereby obtaining a solution comprising purified anti-thrombin-III. Also covered is a solution comprising purified anti-thrombin-III when produced by said process, and pharmaceutical compositions containing said solution.
Patent NZ-519423-A (NZ)
Title: Benzazole derivatives and their use as JNK modulators
Inventor: HALAZY SERGE
IPC: A61P1/04
Filed: 2000-12-20
Abstract: JNK modulator benzazole derivatives of formula (I) and their use in treating disorders of the autoimmune and neuronal systems.
Patent NZ-521514-A (NZ)
Title: A device for supporting a milking member
Inventor: HAYNE JOHN
IPC: A01J5/017
Filed: 2001-03-21
Abstract: Disclosed is a device for supporting a milking member in a milking stall (1) and to a milking stall arrangement. The milking member includes a claw (8), a number of teacups (9) connected to the claw, and a long conduit member (11, 12) connecting the claw to a milk-receiving member (7). The stall includes an enclosing structure (2) defining a space (3) for an animal to be milked, and a passage (4) permitting the animal to enter and/or exit the space. The device (15) includes an arm (16), which has a first end portion and a second end portion and is pivotable between an active milking position and a retracted position between milking operations. The arm includes a member (25) for supporting the milking member in the active and inactive positions. A first stop (41, 23) defines the active position of the arm and a second stop (42, 23) defines the inactive position of the arm.
Patent NZ-523047-A (NZ)
Title: Phenyl derivatives, processes for their preparation and pharmaceutical compositions containing them
Inventor: ERIKSSON TOMAS
IPC: C07D211/58
Filed: 2001-06-14
Abstract: Disclosed are compounds of formula (I), wherein: Z1 is a bond, (CH2)q where q is 1 or 2, Z2 is a bond or CH2, provided that Z1 and Z2 are not both simultaneously a bond, Q is an oxygen or sulphur atom, or a group CH2 or NH, R2 is a substituted phenyl, and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of diseases mediated by modulation of chemokine receptor activity, such as inflammatory diseases, chronic obstructive pulmonary disease and multiple sclerosis.
Patent NZ-523331-A (NZ)
Title: Method of making colour separations for colour printing using two overprinted transparent colours
Inventor: LEE DAVID LANKASTER
IPC: H04N1/54
Filed: 2002-12-20
Abstract: A method of making separations for colour printing using two over-printed transparent inks which comprises: providing a red, green, blue (RGB) encoded initial image; converting the RGB encoded image to a cyan, magenta, yellow (CMY) encoded image; preparing cyan, magenta, and yellow image separations as source images; determining visually selected dominant object colours of the original image; choosing from a colour palette two transparent ink spot colours which best represent the selected dominant object colours; selscting two channels from the cyan, magenta, and yellow source images as first and second channels an assigning a selected transparent spot colour to each channel; superimposing the first and second channels now rendered with the selected spot colours to form a composite image; adjusting greyscale values of the two superimposed spot colour channels to visually produce an image most closely resembling the desired final image; and making new separations of the two channels suitable for preparing printing plates.
Patent NZ-525083-A (NZ)
Title: Method of processing and displaying the operating conditions of a plurality wind power installation
Inventor: WOBBEN ALOYS
IPC: G05B23/02
Filed: 2001-09-08
Abstract: To process and represent the functional status of a plurality of wind power installations, predetermined operation data representative of the serviceability of each of the installations is acquired and evaluated at a data processing installation. At the data processing installation the serviceability status of each of the installations is classified into classes such as serviceable, technical failure, being maintained, a symbol is associated with each wind power installation of group of installations according to the status classification and the type of installation, and the symbols are combined to produce an overview of the whole system status which is stored as an electronic file that is published to an Internet server so that the overview can be inspected by a client addressing the file in the server. The symbols may be correlated to the geographic location of the wind power installations in the overview display.
Patent NZ-526119-A (NZ)
Title: Tilt-up concrete form brace
Inventor: SHAW SCOTT
IPC: E04G13/00
Filed: 2001-11-20
Abstract: A brace (62, fig. 10) for use in tilt-up construction is disclosed. The brace includes a bottom surface and a vertical side surface. The bottom surface of the brace is affixed to a permanent horizontal surface (e.g., a slab) in a manner that allows the brace to be removed without damaging the permanent horizontal surface. The vertical side surface of the brace is attached to a concrete pour form (14). The bottom surface of the brace is affixed to the permanent horizontal surface (10) using an adhesive. Alternatively, a shoe (60) is attached to the permanent horizontal surface and the brace (62) sits in the shoe.
Patent NZ-530087-A (NZ)
Title: Electric cooking hob and method for determining the location of cooking utensils on it
Inventor: PASTORE CRISTIANO
IPC: H05B3/00
Filed: 2003-12-11
Abstract: An electric cooking hob with a plurality of heating elements distributed in a matrix formation below a heat-resistant surface, on which cooking utensils can be located in a random manner as it determines the location, form and dimensions of the utensils by using a signal source and processing means. Each heating element can be energized with a polarity opposite to the polarity of the current used to perform this determination, so that the power source and the signal source can be applied at the same time to different heating elements.
Patent NZ-530537-A (NZ)
Title: Pharmaceutical composition for administration by the nasal route of oestradiol and norethisterone
Inventor: FONKNECHTEN GILLES
IPC: A61K47/48
Filed: 2002-07-18
Abstract: Described is a pharmaceutical composition for nasal delivery of 17-beta-oestradiol and norethisterone. The aqueous solution further contains a specific amount of partly methylated cyclodextrin, which may be randomly partially methylated.
Patent NZ-531547-A (NZ)
Title: Topical compositions and methods for treating pain
Inventor: WILLIAMS ROBERT O
IPC: A61K47/34
Filed: 2002-08-14
Abstract: An emulsion comprising: (a) amitriptyline, (b) ketamine, (c) a lipophilic component, (d) water, or (e) a surfactant, wherein the emulsion is an oil in water emulsion and further comprises a lipophilic intradermal penetration enhancer selected from the group consisting of isopropyl myristate, glycerol monolaurate, glycerol monooleate, glycerol monolinoleate, isopropyl isostearate, isopropyl linoleate, isopropyl myristate/fatty acid monoglyceride combination, isopropyl myristate/ethanol/l-lactic acid combination, isopropyl palmitate, methyl acetate, methyl caprate and methyl laurate. The emulsion is used for the manufacture of topically-applied medicaments for treating pain in a mammal.